# Syfovre

NDC: 73606-020
Generic name: Pegcetacoplan
Labeler / Manufacturer: Apellis Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVITREAL
Marketing started: 20230217

FDA application: NDA217171

## Active ingredients

- PEGCETACOPLAN: 15 mg/.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73606-020"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73606-020
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4434e61-9ec9-4e0e-bd60-45aaa0a87e64